Zika vaccines and therapeutics: landscape analysis and challenges ahead
Abstract Background Various Zika virus (ZIKV) vaccine candidates are currently in development. Nevertheless, unique challenges in clinical development and regulatory pathways may hinder the licensure of high-quality, safe, and effective ZIKV vaccines. Discussion Implementing phase 3 efficacy trials...
Main Authors: | Annelies Wilder-Smith, Kirsten Vannice, Anna Durbin, Joachim Hombach, Stephen J. Thomas, Irani Thevarjan, Cameron P. Simmons |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12916-018-1067-x |
Similar Items
-
Current trends in Zika vaccine development
by: Francisco A. Lagunas-Rangel, et al.
Published: (2017-07-01) -
Now is the time for the Zika virus
by: Salim Mattar V, et al.
Published: (2015-05-01) -
A vaccine effective against Zika virus is theoretically possible but may not be delivered anytime soon
by: Taylor-Robinson AW
Published: (2016-07-01) -
Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity
by: Yongkang Chen, et al.
Published: (2020-01-01) -
Differential Zika Virus Infection of Testicular Cell Lines
by: Luwanika Mlera, et al.
Published: (2019-01-01)